Delivery Order SPE2DB20D3101-SPE2DB25FRDT1
Award Date
3/5/25
Potential Completion Date
3/6/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,572.72, is for the delivery of the prescription medication Xcopri 150 mg tablets. The contract is a firm fixed-price delivery order with a completion date of May 2, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $1,002.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of the pharmaceutical product Xcopri 50 mg tablets. The contract is a firm fixed price delivery order with an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the prescription medication Xcopri (cenobamate) 50 mg tablets. The contract has a ceiling value of $4,903.86 and a period of performance through April 21, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, headquartered in...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,357.92 firm fixed-price contract is for the delivery of XCOPRI 50 MG TABLET 30S, a pharmaceutical product, with a completion date of February 12, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a $1,768.44 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the pharmaceutical product XCOPRI 50 MG TABLET 30S. The contract is not designated with a set-aside, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,431.56 firm fixed-price delivery order is for 4566961705 ! XCOPRI 50 MG TABLET 30S, with an ultimate completion date of January 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,932.72, is a delivery order for the supply of the prescription drug XCOPRI 50 MG TABLET 30S. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of Xcopri 50 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,247.98, was awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for a period ending on August 21, 2024. This is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a total potential value of up to $999,999,999 through December...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,445.44 firm fixed-price contract is for the delivery of XCOPRI 50 MG TABLET 30S, a pharmaceutical product, with a completion date of May 3, 2023. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication XCOPRI 100 MG TABLET 30S. The contract has a firm fixed price of $1,178.96 and a completion date of April 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...